AVA Genomics Consultancy ApS: Financial statements 2023
CVR: 37493678
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
AVA Genomics Consultancy ApS (CVR 37493678) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -36,889 and a net result of DKK -37,139 compared with DKK -19,897 the year before. Equity in the 2023 report amounted to DKK -17,036.
- Gross Profit
- DKK -36,889
- Profit/Loss
- DKK -37,139
- Equity
- DKK -17,036
- Total Assets
- DKK 26,095
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -37 t. | -37 t. | -17 t. | - |
| 2022 | - | -19 t. | -20 t. | 20 t. | - |
| 2021 | - | 34 t. | 25 t. | 35 t. | 1 |
| 2020 | - | -117 | -135 | 10 t. | 0 |
| 2019 | - | 18 t. | 10 t. | 10 t. | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
AVA Genomics Consultancy ApS has published its annual report for 2022. Gross profit came to DKK -18,813, and the net result was DKK -19,897.
About AVA Genomics Consultancy ApS
AVA Genomics Consultancy ApS is a Danish company of the type Anpartsselskab based in Randers SV, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named AVA Genomics and Breeding Consultancy IVS. The management consists of Haja Najeemudin Kadarmideen. The company is owned by Haja Najeemudin Kadarmideen. The company has 1 employee (2026). In 2026, the company reported a gross profit of DKK 14,728 and a net result of DKK -4,294 compared with DKK -18,733 the year before. Equity in the 2026 report amounted to DKK 90,595.